光动力疗法
医学
重症监护医学
炎症
不利影响
光敏剂
高脂血症
生物信息学
免疫学
药理学
生物
糖尿病
化学
有机化学
内分泌学
作者
Yanqing Lin,Ruosen Xie,Changyuan Yu
出处
期刊:Pharmaceutics
[Multidisciplinary Digital Publishing Institute]
日期:2024-05-29
卷期号:16 (6): 729-729
被引量:15
标识
DOI:10.3390/pharmaceutics16060729
摘要
This review paper examines the evolution of photodynamic therapy (PDT) as a novel, minimally invasive strategy for treating atherosclerosis, a leading global health concern. Atherosclerosis is characterized by the accumulation of lipids and inflammation within arterial walls, leading to significant morbidity and mortality through cardiovascular diseases such as myocardial infarction and stroke. Traditional therapeutic approaches have primarily focused on modulating risk factors such as hypertension and hyperlipidemia, with emerging evidence highlighting the pivotal role of inflammation. PDT, leveraging a photosensitizer, specific-wavelength light, and oxygen, offers targeted treatment by inducing cell death in diseased tissues while sparing healthy ones. This specificity, combined with advancements in nanoparticle technology for improved delivery, positions PDT as a promising alternative to traditional interventions. The review explores the mechanistic basis of PDT, its efficacy in preclinical studies, and the potential for enhancing plaque stability and reducing macrophage density within plaques. It also addresses the need for further research to optimize treatment parameters, mitigate adverse effects, and validate long-term outcomes. By detailing past developments, current progress, and future directions, this paper aims to highlight PDT's potential in revolutionizing atherosclerosis treatment, bridging the gap from experimental research to clinical application.
科研通智能强力驱动
Strongly Powered by AbleSci AI